Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):330-342. doi: 10.3760/cma.j.issn.1007-3418.2019.05.003.
Malnutrition is common in patients with end-stage liver disease (ESLD) and is an independent risk factor for survival, therefore it should be treated as the same important guideline as ascites and hepatic encephalopathy. However, up to now, there is no clinical nutrition guideline for patients with ESLD in China. In order to standardize the nutrition treatment, Chinese Society of Hepatology (CSH) and Chinese Society of Gastroenterology (CSGE), Chinese Medical Association(CMA) co-organized and co-developed this guideline. Recommendations on nutritional screening and assessment as well as principles of intervention and management in patients with ESLD were provided to help clinicians make rational decisions on clinical malnutrition.
营养不良在终末期肝病（ESLD）患者中很常见，并且是影响生存的独立危险因素，因此应将其作为与腹水和肝性脑病同等重要的指导原则进行治疗。然而，到目前为止，中国尚无针对ESLD患者的临床营养指南。为规范营养治疗，中华医学会肝病学分会（CSH）、中华医学会消化病学分会（CSGE）联合组织并共同制定了本指南。本指南提供了ESLD患者营养筛查与评估的建议以及干预和管理原则，以帮助临床医生对临床营养不良做出合理决策。
